The World Anti-Doping Company is not going to attraction in opposition to the ban given to Poland’s Iga Swiatek.
The five-time main winner examined constructive for coronary heart medicine trimetazidine (TMZ) in an out-of-competition pattern in August 2024.
The Worldwide Tennis Integrity Company (ITIA) accepted the take a look at consequence was attributable to contamination and the world quantity two served a one-month suspension, which ended on 4 December.
“I am simply happy I can get a closure, type of, and I can simply transfer on and end this entire course of,” stated Swiatek after she beat Eva Lys to achieve the quarter-finals of the Australian Open.
“I simply wish to play tennis and concentrate on the match. It is good that the method is over.”
Wada stated that “following an intensive assessment, it is not going to lodge an attraction to the Courtroom of Arbitration for Sport (Cas)” within the 23-year-old’s case.
“Wada’s scientific specialists have confirmed the precise contaminated melatonin situation, as introduced by the athlete and accepted by the ITIA, is believable and that there can be no scientific grounds to problem it at Cas,” learn a Wada assertion.
“Wada sought recommendation from exterior authorized counsel, who thought of the athlete’s contamination clarification was nicely evidenced, that the ITIA determination was compliant with the World Anti-Doping Code, and that there was no affordable foundation to attraction it to the Cas.”
Males’s world primary Jannik Sinner didn’t obtain a ban after failing two checks in March and Wada has appealed in opposition to that call.
